An Interventional, Open-Label, Randomized, Multicenter, Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in The Neoadjuvant Settin
An Interventional, Open-Label, Randomized, Multicenter, Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone…
Read the full articleYou might also wanna read
EBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK Democratic Republic of the Congo
iarc.who.int·2h ago
The Midwife Who Also Sits With the Dying
bialikbreakdown.substack.com·2h ago
South Korean chemists develop UV-activated self-healing contact lenses
sciencealert.com·5h ago
Study reveals how opposing oncogenic and tumor-suppressive forces converge to drive benign-to-malignant transition in pancreatic cancer
cell.com·7h ago
Tiny tick bites can cause big health problems – these tips can help
Environmental Working Group·8h ago
WHO South Africa 2026 2nd Quarter Newsletter (April-June)
iarc.who.int·9h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.